Ocugen, Inc. Banner Image

Ocugen, Inc. has reached its limit for free report views

Work for Ocugen, Inc.? Upgrade Your Profile and unlock all your annual reports.

Ocugen, Inc.

  • Ticker OCGN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Ocugen, Inc. Logo Image
  • 11-50 Employees
  • Based in Malvern, Pennsylvania
Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases. Their breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug – “one to many” and their novel biologic product candidate aims to offer better therapy to patients with underserved diseasesMore such as wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy.
Ocugen, Inc.

Most Recent Annual Report

Ocugen, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Report Locked. Ocugen, Inc. has reached its limit for free report views.

Older/Archived Annual Reports